0001104659-16-107167.txt : 20160323
0001104659-16-107167.hdr.sgml : 20160323
20160323163106
ACCESSION NUMBER: 0001104659-16-107167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160322
FILED AS OF DATE: 20160323
DATE AS OF CHANGE: 20160323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc.
CENTRAL INDEX KEY: 0001626199
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208969493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-945-7700
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Congleton Jon
CENTRAL INDEX KEY: 0001644975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37449
FILM NUMBER: 161524241
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
a4.xml
4
X0306
4
2016-03-22
0
0001626199
Nivalis Therapeutics, Inc.
NVLS
0001644975
Congleton Jon
C/O NIVALIS THERAPEUTICS, INC.
3122 STERLING CIRCLE, SUITE 200
BOULDER
CO
80301
1
1
0
0
President and CEO
Common Stock
2016-03-22
4
P
0
5000
4.3815
A
10000
D
The price recorded in Column 4 represents the actual price for the full block purchase.
/s/ R. Michael Carruthers, Attorney-in-Fact
2016-03-23